Glipizide and Pomalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glipizide (glipizide) and Pomalidomide (pomalidomide). Common drug interactions include plasma cell myeloma among females and bacteraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Glipizide and Pomalidomide. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Pomalidomide?

Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.

On Jul, 12, 2026

36 people who take Glipizide and Pomalidomide together, and have interactions are studied.

Glipizide and Pomalidomide drug interactions.

What are the common drug interactions of Glipizide and Pomalidomide, by gender? *:

female:

Plasma cell myeloma (cancer that begins in plasma cells)
Influenza
Platelet count decreased
White blood cell count decreased
Confusional state
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Malignant neoplasm progression (cancer tumour came back)
Peripheral swelling
Abdominal pain upper

male:

Bacteraemia (presence of bacteria in the blood)
Cholecystitis (infection of gallbladder)
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Blood creatinine increased
Death
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dermatitis allergic (inflammation of the skin due allergic reaction)
Hepatic enzyme increased
Herpes simplex (herpes simplex is a common viral infection)
Hypokalaemia (low potassium)

What are the common drug interactions of Glipizide and Pomalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Febrile neutropenia (fever with reduced white blood cells)
Hypovolaemic shock (shock caused by severe blood or fluid loss)
Pyrexia (fever)

60+:

Bacteraemia (presence of bacteria in the blood)
Cholecystitis (infection of gallbladder)
Platelet count decreased
Rash
White blood cell count decreased
Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
Confusional state
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Malignant neoplasm progression (cancer tumour came back)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 34 people, 94.44%
High Blood Pressure: 4 people, 11.11%
Nausea (feeling of having an urge to vomit): 3 people, 8.33%
Type 2 Diabetes: 2 people, 5.56%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 5.56%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 5.56%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 5.56%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 2 people, 5.56%
Asthma: 2 people, 5.56%
Arrhythmias (irregular heartbeat): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and Pomalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously